Stockscreener 앱 받기
12.70
4.35%
0.53
전일 마감가:
$12.17
열려 있는:
$12.09
하루 거래량:
788.71K
Relative Volume:
4.40
시가총액:
$183.17M
수익:
$6.39M
순이익/손실:
$-117.26M
주가수익비율:
-1.0176
EPS:
-12.4807
순현금흐름:
$-79.08M
1주 성능:
-2.23%
1개월 성능:
+3.00%
6개월 성능:
+56.40%
1년 성능:
+2.92%
1일 변동 폭
$12.09
$13.14
1주일 범위
$11.97
$15.09
52주 변동 폭
$5.2044
$55.89
Korro Bio Inc Stock (KRRO) Company Profile
명칭
Korro Bio Inc
전화
617-468-1999
주소
60 FIRST STREET, CAMBRIDGE
Compare KRRO vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KRRO
Korro Bio Inc
|
12.70 | 183.17M | 6.39M | -117.26M | -79.08M | -12.48 |
VRTX
Vertex Pharmaceuticals Inc
|
491.34 | 124.70B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
632.90 | 66.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
887.18 | 55.17B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
291.37 | 38.90B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
182.08 | 38.71B | 742.00K | -1.37B | -1.07B | -7.0731 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2026-02-17 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2026-01-29 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2026-01-29 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2026-01-29 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2026-01-28 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2026-01-28 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-11-13 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2025-11-13 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2025-11-13 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-11-13 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-11-13 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-11-13 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2025-11-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-04-16 | 개시 | Chardan Capital Markets | Buy |
| 2025-01-10 | 개시 | Oppenheimer | Outperform |
| 2024-10-21 | 개시 | Raymond James | Strong Buy |
| 2024-08-14 | 개시 | William Blair | Outperform |
| 2024-03-28 | 재확인 | H.C. Wainwright | Buy |
| 2024-02-27 | 개시 | BMO Capital Markets | Outperform |
| 2023-12-04 | 개시 | H.C. Wainwright | Buy |
| 2023-11-29 | 개시 | RBC Capital Mkts | Outperform |
| 2023-11-10 | 개시 | Piper Sandler | Overweight |
| 2023-02-15 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2023-02-13 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2021-09-22 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-01-27 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-12-22 | 개시 | B. Riley Securities | Buy |
| 2020-07-14 | 개시 | Oppenheimer | Outperform |
| 2020-05-18 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-10-28 | 개시 | Cowen | Outperform |
| 2019-10-28 | 개시 | Goldman | Buy |
| 2019-10-28 | 개시 | JP Morgan | Overweight |
모두보기
Korro Bio Inc 주식(KRRO)의 최신 뉴스
Korro Bio, Inc. (KRRO) soars 17.6%: Is further upside left in the stock? - MSN
Korro Bio, Inc. Actuals & Estimates (NASDAQ:KRRO) - TradingView
KRRO Forecast — Price Target — Prediction for 2027 - TradingView
Form 4 Korro Bio Inc For: 24 June By Investing.com - Investing.com Nigeria
Korro Bio Insider Sold Shares Worth $2,458,582, According to a Recent SEC Filing - marketscreener.com
Korro Bio director Jean Francois Formela sells $2.45m in shares - Investing.com
Form 144 Korro Bio For: 24 June By Investing.com - Investing.com Canada
Atlas Venture (KRRO) sells 101,579 shares on 06/23/2026, multiple Form 144 entries - Stock Titan
Korro Bio Inc (KRRO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Form 144 Korro Bio For: 23 June By Investing.com - Investing.com South Africa
Form 144 Korro Bio For: 22 June By Investing.com - Investing.com Australia
Atlas Venture sells KRRO (KRRO) stock — 2,441 and 419 shares reported - Stock Titan
Korro Bio, Inc. (KRRO) Soars 17.6%: Is Further Upside Left in the Stock? - Yahoo Finance
Korro Bio COO Chappell sells $34,309 in company stock By Investing.com - Investing.com South Africa
Korro Bio COO Chappell sells $34,309 in company stock - Investing.com UK
Korro Bio Inc (KRRO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Korro Bio Inc (KRRO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Korro Bio Inc (KRRO) Institutional Confidence - TradingKey
Korro Bio Inc (KRRO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Korro Bio Inc (KRRO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Korro Bio Inc (KRRO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Korro Bio Inc (KRRO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Korro Bio Inc (KRRO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Korro Bio (KRRO) CSO sells 3,418 shares to cover RSU taxes - Stock Titan
Korro Bio: RNA Editor Plots Way Back After AATD Study FailI'm Holding (NASDAQ:KRRO) - Seeking Alpha
KRRO Q1 2026 Earnings: Narrowed Loss Surprises to the Upside, Shares RallyEarnings Surprise Stocks - newsline.com
KORRO BIO INC (KRRO) Stock Chart - ChartMill
Korro Bio Stockholders Approve Directors, Pay and Auditor - The Globe and Mail
Korro Bio (KRRO) director Ali Behbahani receives 14,677 stock options grant - Stock Titan
Korro Bio (KRRO) director receives 14,677 stock options at $10.59 strike - Stock Titan
Korro Bio (KRRO) director Nessan Bermingham receives 14,677 stock options at $10.59 - Stock Titan
Korro Bio (KRRO) director awarded 14,677 stock options at $10.59 strike price - Stock Titan
Director at Korro Bio (NASDAQ: KRRO) awarded stock options for 14,677 shares - Stock Titan
Korro Bio (NASDAQ: KRRO) director receives 14,677 stock options grant - Stock Titan
What makes Korro Bio, Inc. (KRRO) a new buy stock - MSN
Korro Bio (NASDAQ: KRRO) investors back directors, pay and auditor - Stock Titan
One Korro Bio Insider Raised Stake By 19% In Previous Year - Yahoo Finance
KRRO Q1 2026 Earnings: Narrower-than-expected loss drives positive surprise despite revenue absencePerformance Review - newsline.com
KRRO Q1 2026 Earnings: EPS Beat But Stock Declines Amid No RevenueAnnual Report - newsline.com
KRRO Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost Discipline Amid Pre-Revenue PhaseManagement Tone Analysis - newsline.com
Korro Bio CEO Ram Aiyar sells $196,672 in company stock By Investing.com - Investing.com Nigeria
Korro Bio CEO Ram Aiyar sells $196,672 in company stock - Investing.com
Korro Bio director sells $39,897 in common stock By Investing.com - Investing.com Canada
Korro Bio director sells $39,897 in common stock - Investing.com
Korro Bio Inc. (KRRO) Faces Selling Pressure as Shares Retreat 3.21%Bear Pennant - The Legal Advocate
KRRO Q1 2026 Earnings: EPS Beat by 10.05% as Biotech Advances PipelineNext Quarter Guidance - The Legal Advocate
Korro Bio Inc (KRRO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Korro Bio Inc 주식 (KRRO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| FORMELA JEAN FRANCOIS | Director |
Jun 24 '26 |
Sale |
14.61 |
48,438 |
707,491 |
169,556 |
| FORMELA JEAN FRANCOIS | Director |
Jun 22 '26 |
Sale |
13.95 |
3,962 |
55,270 |
194,075 |
1.36%
자본화:
|
볼륨(24시간):